Trial Profile
Treatment With Crizotinib Single Patient Expanded Access IND 134375
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 01 Sep 2017
Price :
$35
*
At a glance
- Drugs Crizotinib (Primary)
- Indications Muscle tissue neoplasms
- Focus Expanded access; Therapeutic Use
- 23 Mar 2017 New trial record